A cancer diagnosis often comes with overwhelming emotions and a flood of unfamiliar medical terms that can spark even more fear. But understanding these terms can help you feel more in control of your ...
Ruxolitinib (a JAK2 inhibitor) and belumosudil (a ROCK2 inhibitor) have recently been approved by the Food and Drug Administration (FDA) for the treatment of chronic graft-versus-host disease (GVHD).
Pathologic response rates to neoadjuvant pembrolizumab in locally advanced (LA) resectable cutaneous squamous cell carcinoma (cSCC). This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting ...
Dr. Chris Holsinger shares the new guideline from ASCO on transoral robotic surgery (TORS) for patients with oropharyngeal squamous cell carcinoma. He reviews the evidence-based recommendations on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback